image
TG Therapeutics, Inc. TGTX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 37.25
-0.268 %
$ 5.85 B
Market Cap
248.33
P/E
INCOME STATEMENT
329 M REVENUE
40.80%
Growth Rates
1Year 40.80%
3Years 266.39%
5Years 364.59%
7Years 199.45%
10Years 115.49%
41.9 M OPERATING INCOME
103.21%
Growth Rates
1Year 103.21%
3Years 28.50%
5Years 17.59%
7Years 13.00%
10Years 10.66%
23.4 M NET INCOME
84.52%
Growth Rates
1Year 84.52%
3Years 27.39%
5Years 16.38%
7Years 11.90%
10Years 9.24%
EFFICIENCY
Earnings Waterfall TG Therapeutics, Inc.
image
Revenue 329 M
Cost Of Revenue 38.5 M
Gross Profit 291 M
Operating Expenses 249 M
Operating Income 41.9 M
Other Expenses 18.5 M
Net Income 23.4 M
350m350m300m300m250m250m200m200m150m150m100m100m50m50m00329m(38m)291m(249m)42m(19m)23mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996
REVENUE
Revenue 329.0 233.7 2.8 6.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 19 K 0 0 0 0 0 0 0 0 0 0.5 2.7 5.4 1.2 3.0 100 K 100 K
GROSS PROFIT
Cost Of Revenue 38.5 14.1 0.3 0.8 0.4 0.3 88 K 82.4 K 63 K 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.1 4.1 0.8 (0.2) 100 K 0
Gross Profit 290.5 219.5 2.5 5.9 (0.2) (0.1) 64 K 70 K 89.4 K 0.2 0.2 0.2 19 K 0 0 0 0 0 0 0 0 0 0.5 0.6 1.3 0.4 3.2 0.2 100 K
OPERATING INCOME
Operating Expenses 248.6 198.9 195.4 350.7 273.7 169.2 174.6 118.9 79.1 63.3 55.9 20.3 25.8 0.9 2.0 1.8 4.4 12.1 10.0 19.4 6.1 4.8 2.1 3.7 4.5 3.1 5.9 5.5 3.9
Selling, General and Administrative Expenses 154.3 122.7 83.2 152.1 121.8 20.8 20.8 22.0 12.6 19.9 24.5 7.7 5.2 0.6 1.5 1.7 2.6 3.6 3.8 2.3 2.0 1.8 1.5 2.9 3.3 1.9 2.7 2.8 2.8
Research and Development Expenses 94.3 76.2 112.1 198.5 151.9 148.4 153.8 96.9 66.5 43.4 31.4 12.6 20.6 0.3 0.5 40.4 K 1.8 8.5 6.2 17.1 4.2 1.7 0.5 0.9 1.1 1.1 3.0 2.6 1.1
Operating Income 41.9 20.6 (192.8) (344.8) (273.6) (169.1) (174.4) (118.7) (79.0) (63.2) (55.7) (23.0) (26.9) (0.9) (2.0) (1.8) (4.4) (12.1) (10.0) (19.4) (6.1) (4.8) (1.6) (3.1) (3.2) (2.7) (2.7) (5.3) (3.8)
PRE-TAX INCOME
Interest Income Expense 24.0 12.6 10.2 5.6 6.3 5.3 1.7 1.1 0 1.0 0.9 1.0 0.9 7.1 K 1.3 0.5 64.8 K 476 1.66 K 0 0 0 0 0 0 0 0 0 0
Total Other Income (16.3) (7.6) (5.5) (3.3) (5.8) (3.8) 0.9 0.2 0.7 0.2 60.2 K (0.3) 62.6 K 7.1 K 3.4 (0.5) 0.4 0.1 1 K 5.85 K 71.2 K (2.5) (0.5) 1.3 (2.7) 0 0 0.2 0.2
Pre-Tax Income 25.6 13.1 (198.3) (348.1) (279.4) (172.9) (173.5) (118.5) (78.3) (62.9) (55.8) (20.5) (25.9) (0.9) 1.3 (2.8) (4.7) (12.0) (10.0) (19.4) (6.1) (7.2) (1.6) (1.8) (5.9) 0 0 (5.1) (3.6)
NET INCOME
Tax Provision 2.2 0.4 5.5 7.5 6.5 6.5 (0.9) (0.2) (0.7) (0.2) 60.2 K (2.5) 0.3 36 K (2.6) 1.0 (0.1) (0.1) (0.3) (0.2) (0.2) 1.2 5.98 K (1.4) 2.6 (0.3) 100 K 100 K (0.2)
Net Income 23.4 12.7 (203.8) (355.6) (285.9) (179.3) (173.5) (118.5) (78.3) (62.9) (55.8) (20.5) (18.1) (0.9) 0.6 (2.8) (4.3) (12.0) (9.7) (19.1) (5.9) (6.0) (1.5) (1.7) (5.8) (2.4) (2.8) (5.2) (3.6)
EPS 0.16 0.0893 1.51 2.69 2.48 2.03 2.3 1.91 1.6 1.38 1.64 0.81 1.38 0.44 15.7 111 170 498 454 1.24 K 616 749 348 1.53 K 13.3 K 7.02 K 8.75 K 23.9 K 17.4 K